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She first large national cardiology meeting I attended was
he American Heart Association Scientific Sessions in 1973.
was awed with the content and spectacle of the conven-
ion. Over the years, these national (and now international)
eetings have evolved both for better and for worse.
The major cardiology meetings continue to be stunning
n breath of subject matter and depth of expertise. They
ring together at one place and time almost all the leading
uthorities and pioneering researchers in nearly every area of
ardiovascular medicine. Important research findings are
resented by the responsible investigators to their peers.
tate-of-the-Art reviews of every facet of cardiovascular
isease are presented at levels appropriate for experts and for
ovices. The material is presented in multiple formats to
ccommodate the varying preferences of the attendees.
The medical presentations are accompanied by an all-
ncompassing industrial exhibit. Equipment for invasive
nd noninvasive procedures, the entire spectrum of phar-
acologic agents, and medical textbooks and journals are all
n display. It provides the ideal venue for those about to
urchase equipment and those seeking to keep up with new
echnology. The industrial exhibits also provide much of the
pectacle of the meeting. The glitz of the booths, the visuals
resented on boards and screens, the countless company
epresentatives eager to discuss every facet of their products
ll contribute to the sense of a space-age medical bazaar.
As cardiovascular medicine and surgery have grown, so
as the size of the major meetings, somewhat to the
etriment of the program. It used to be possible to move
etween sessions in different rooms, even between individ-
al abstracts. The meetings are now so large and spread out
hat you need to be well conditioned just to get from one
nd of the convention to the other. With rare exception, it
s usually easier to choose a session and remain in the room
he entire time. This can be frustrating since there are so
any important and interesting sessions occurring simulta-
eously. The meetings used to provide an opportunity to
atch up with colleagues and see old friends. You can no
onger rely on bumping into people in the hall. The crowds
nd the distances at the meetings have made them feel more
mpersonal.
Another change in the national meetings has been the
ncreasing emphasis on public relations. Tabloids are dis-
ributed on a daily basis extolling the important presenta- oions which have been made and highlighting those which
re to come. Television monitors present this same infor-
ation in the hallways of the convention center and in our
otel rooms, and once even in the buses that transported us.
he findings presented at the meeting receive prominent
overage in the national press and television. As one of my
olleagues remarked “the meetings are like one big press
onference.” It is easy to get the impression that receiving
edia attention has now become one of the principle goals
f the meeting and one of the major criteria of success for
he participants.
The prominence of media highlights is expressed to some
egree in the phenomenon of Late-Breaking Clinical Trials
LBCTs). No one could argue with the fact that promptly
eleasing data that could impact clinical care is preferable to
aiting months before the next major meeting. However,
BCTs seem to have taken on a life of their own. The
esignation of “late-breaking” has come to convey a sense of
mportance and credibility in and of itself. The trials that are
resented receive prominent media coverage. Prestigious
ournals jockey to obtain submission of LBCT manuscripts,
ith letters of solicitation and direct contacts from the
ditorial office offering special expedited processing. The
pitome of the achievement for late-breaking phenomenon
s simultaneous publication (in print or online) at the time
f presentation. Given the attention and importance ac-
orded to these trials, one wonders if investigators might not
e incented to time completion of their analysis just so that
t can be designated as “late-breaking.”
There are several aspects of the late-breaking phenome-
on that raise concern. Given that the results of LBCTs are
enerally not known at the time they are selected for
resentation, it is not surprising that the findings neither are
lways definitive nor provide the basis to alter clinical care.
For this year’s American College of Cardiology meeting,
bstracts received in January were required to provide a
trong promissory note that the results would be available,
ut not the results themselves). Therefore, the data pre-
ented may be preliminary or incomplete. However, the
reliminary nature of the findings is frequently lost in the
anfare surrounding the presentation, and results are often
isseminated online and in the media with an air of finality.
econd, even when the data analysis is complete, the process
f external peer review has not occurred. Clearly, peer
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April 19, 2005:1304–5 Editor’s Pageeview is important not only in assuring accuracy, but also in
nhancing the analysis and presentation of the data. As a
nal concern, expedited analysis and review may not provide
ufficient time to identify all of the issues, nuances, and
mplications of the data by either the authors or the
eviewers. The Letters to the Editor section offers evidence
f issues identified even after the findings appear in print. In
um, LBCTs carry the danger of presenting preliminary
esults with the aura of great importance and credibility, and
isseminating them widely to the profession and the public
n the absence of standard peer-review scrutiny.
Several steps would seem to be in order to avoid the
otential dangers of LBCTs. First, investigators should be
rohibited from presenting preliminary data, even if it
equires withdrawing the presentation from the program.
econd, transmission of findings to the profession and
ublic should be done cautiously and with emphasis on the
ack of a full peer-review. The release of the text and
raphics of the presentation conveys a finality that usually
oes not exist. Third, it is my opinion that the medical and
on-medical community would usually be better served by
voiding a rush to publication and allowing some time for
eflection by the authors, reviewers, and cardiovascular Eommunity in general. Finally, it seems to me that we would
o well to rethink the emphasis and exposure given to
BCTs by our major meetings.
I have not missed attending a national meeting since
973, and with any luck I will not miss any in the
oreseeable future. For all of their imperfections, they
rovide something unavailable in any other venue. In terms
f the national meeting itself, its limitations (size, imper-
onality, glitz) appear to be inextricably linked to its unique
alues (diversity, expertise, exposure to products). I guess
ou have to take the good with the bad. However, I do
elieve it would serve us well to temper the emphasis on the
edia and press conferences. Regarding LBCTs, it is my
iew that we are on a problematic course. I urge the major
ardiology societies to seriously consider the refinements
uggested within this paper. The potential impact of im-
ortant clinical trials on patient care is too great to risk for
n exaggerated sense of significance and urgency.
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